Status:
COMPLETED
Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19
Lead Sponsor:
Izmir Democracy University
Conditions:
COVID-19 Respiratory Infection
Parkinson Disease
Eligibility:
All Genders
18+ years
Brief Summary
To comparative pain intensity, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with post-COVID-19 and without post-COVID-19 was ai...
Detailed Description
Acute worsening and long-term sequelae of motor and non-motor symptoms have also been described in Parkinson's patients during and after SARS-CoV-2 infection, which is also known as prolonged COVID. T...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Parkinson's patients with post-COVID-19;
- Being diagnosed with COVID-19 at least 12 weeks ago and recovered,
- Being over 18 years old,
- Volunteering to participate in the research,
- Being diagnosed with Parkinson's disease
- Comorbid conditions (such as hypertension, diabetes) are under control
- Being able to perceive assessments (Standardized Mini Mental Test score of 24 and above)
- Having the ability to ambulate and walk independently
- Being in stage 1 - 4 according to the Modified Hoehn-Yahr Scale
- Inclusion criteria for Parkinson's patients without post-COVID-19;
- Not being diagnosed or suspected of COVID-19
- Being over 18 years old,
- Volunteering to participate in the research,
- Being diagnosed with Parkinson's disease
- Having comorbid conditions (such as hypertension, diabetes) which are under control
- Being able to perceive assessments (Standardized Mini Mental Test score of 24 and above)
- Having the ability to ambulate and walk independently
- Being in stage 1 - 4 according to the Modified Hoehn-Yahr Scale
- Exclusion criteria for Parkinson's patients with and without post-COVID-19;
- Sudden drug or dose change during the study period
- A history of any acute/chronic orthopedic, cardiovascular, pulmonary, psychiatric or neuromuscular disease that may prevent measurements from being made.
- Having had myocardial infarction and pulmonary embolism in the last 30 days,
- Having a history of additional neurological (stroke, head trauma, peripheral nerve diseases, brain and spinal cord tumors, etc.) diseases other than Parkinson's disease
- Having severe vision loss or vestibular dysfunction
- Patients with blood pressure values above 140/90 and below 90/50 in blood pressure measurements made before the study, with arrhythmia on ECG, with a history of shortness of breath and/or palpitation
Exclusion
Key Trial Info
Start Date :
May 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06008444
Start Date
May 13 2023
End Date
December 30 2024
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Izmir Democracy University
Izmir, Turkey (Türkiye), 35140